Evidence map›Paper›PMID 38243054›Full record

ArticleScientific reports2024

"KAIZEN" method realizing implementation of deep-learning models for COVID-19 CT diagnosis in real world hospitals.

Naoki Okada, Yutaka Umemura, Shoi Shi, Shusuke Inoue, Shun Honda, Yohsuke Matsuzawa, Yuichiro Hirano, Ayano Kikuyama, Miho Yamakawa, Tomoko Gyobu and 18 more

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Naoki OkadaOsaka General Medical Center, Osaka, Japan. wggdilp@gmail.com.
Yutaka UmemuraOsaka General Medical Center, Osaka, Japan.
Shoi ShiUniversity of Tsukuba, Tsukuba, Japan.
Shusuke Inouefcuro Inc., Osaka, Japan.
Shun Hondafcuro Inc., Osaka, Japan.
Yohsuke MatsuzawaOsaka Metropolitan University, Osaka, Japan.
Yuichiro Hiranofcuro Inc., Osaka, Japan.
Ayano KikuyamaOsaka General Medical Center, Osaka, Japan.
Miho YamakawaOsaka General Medical Center, Osaka, Japan.
Tomoko GyobuOsaka General Medical Center, Osaka, Japan.
Naohiro HosomiOsaka General Medical Center, Osaka, Japan.
Kensuke MinamiOsaka General Medical Center, Osaka, Japan.
Natsushiro MoritaOsaka General Medical Center, Osaka, Japan.
Atsushi WatanabeOsaka General Medical Center, Osaka, Japan.
Hiroyuki YamasakiShizuoka Saiseikai General Hospital, Shizuoka, Japan.
Kiyomitsu FukaguchiShonan Kamakura General Hospital, Kamakura, Japan.
Hiroki MaeyamaTsuyama Chuo Hospital, Tsuyama, Japan.
Kaori ItoTeikyo University, Tokyo, Japan.
Ken OkamotoJuntendo University Urayasu Hospital, Urayasu, Japan.
Kouhei HaranoShowa University Hospital, Tokyo, Japan.
Naohito MeguroTokyo Women's Medical University Hospital, Tokyo, Japan.
Ryo UnitaNational Hospital Organization Kyoto Medical Center, Kyoto, Japan.
Shinichi KoshibaShizuoka Saiseikai General Hospital, Shizuoka, Japan.
Takuro EndoInternational University of Health and Welfare, School of Medicine, Narita Hospital, Narita, Japan.
Tomonori YamamotoNara Prefecture General Medical Center, Nara, Japan.
Tomoya YamashitaOsaka City General Hospital, Osaka, Japan.
Toshikazu ShinbaShizuoka Saiseikai General Hospital, Shizuoka, Japan.
Satoshi FujimiOsaka General Medical Center, Osaka, Japan.

Funding

Japanese Cabinet Secretariat 438-2020-5EJapanese Cabinet Secretariat 834-2021-4AJapanese Cabinet Secretariat 847-2022-2CJapanese Cabinet Secretariat 847-2022-2D
6 · The paper itself

Abstract

Numerous COVID-19 diagnostic imaging Artificial Intelligence (AI) studies exist. However, none of their models were of potential clinical use, primarily owing to methodological defects and the lack of implementation considerations for inference. In this study, all development processes of the deep-learning models are performed based on strict criteria of the "KAIZEN checklist", which is proposed based on previous AI development guidelines to overcome the deficiencies mentioned above. We develop and evaluate two binary-classification deep-learning models to triage COVID-19: a slice model examining a Computed Tomography (CT) slice to find COVID-19 lesions; a series model examining a series of CT images to find an infected patient. We collected 2,400,200 CT slices from twelve emergency centers in Japan. Area Under Curve (AUC) and accuracy were calculated for classification performance. The inference time of the system that includes these two models were measured. For validation data, the slice and series models recognized COVID-19 with AUCs and accuracies of 0.989 and 0.982, 95.9% and 93.0% respectively. For test data, the models' AUCs and accuracies were 0.958 and 0.953, 90.0% and 91.4% respectively. The average inference time per case was 2.83 s. Our deep-learning system realizes accuracy and inference speed high enough for practical use. The systems have already been implemented in four hospitals and eight are under progression. We released an application software and implementation code for free in a highly usable state to allow its use in Japan and globally.

Indexed as

COVID-19Deep LearningArtificial IntelligenceCOVID-19 TestingHumansSoftwareTomography, X-Ray Computed

Identifiers

PMID38243054
PMCPMC10799049

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.